Arena Pharma (ARNA), Eisai Announces Availability of New Once-Daily BELVIQ XR
Tweet Send to a Friend
Eisai Inc. and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced the availability of BELVIQ XR (lorcaserin HCl) CIV extended-release 20 mg ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
